Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Novo Nordisk A/S
DUS:NOVA
Novo Nordisk A/S
DUS:NOVA
Price:
34.82
EUR
-1.14%
Market Closed
Market Cap:
€117.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novo Nordisk A/S
DUS:NOVA
|
DK |
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
|
C
|
Carter's Inc
XMUN:HCH
|
US |
|
A
|
Avaco Co Ltd
KOSDAQ:083930
|
KR |
|
M
|
MediciNova Inc
TSE:4875
|
US |
|
Agatos SpA
MIL:AGA
|
IT |
|
Kitron ASA
OSE:KIT
|
NO |
|
A
|
Addus Homecare Corp
F:A41
|
US |
Wall St Price Targets
NOVA Price Forecast
Based on 32 analysts
Based on 32 analysts
+16% Upside
from
€34.82
today
Novo Nordisk A/S (NOVA)’s 12-month stock price forecast through October 2027 has a consensus target of €40.24, implying 16% upside. The forecast is based on price targets from 32 Wall Street analysts.
NOVA Analyst Rating
No ratings yet
No ratings yet
Novo Nordisk A/S Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOVA's stock price target?
Price Target
40.24
EUR
40.24
EUR
According to Wall Street analysts, the average 1-year price target for NOVA is 40.24 EUR with a low forecast of 27.33 EUR and a high forecast of 62.28 EUR.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
2%
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 2%.
What is the Gross Profit forecast for Novo Nordisk A/S?
Projected CAGR
2%
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
0%
0%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 0%.
What is the Pre-Tax Income forecast for Novo Nordisk A/S?
Projected CAGR
0%
0%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
-1%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is -1%.